Waystar Holding Corp. (WAY)

Waystar is a healthcare-payments software company in a genuine profitability inflection: first GAAP-profitable year in 2025, ~18-20% revenue growth accelerating in H1 2026, net revenue retention above 100%, clean SEC filings with no going-concern issues and a 2029 debt maturity. But it trades at a premium (~34x TTM earnings, ~14x EV/EBITDA), returns on equity remain thin (~3.5%) due to a goodwill-heavy balance sheet, net retention is slipping from 112% to 108%, and Bain/CPPIB/EQT sponsor distributions plus routine insider selling create overhang. DCF outputs implying several-hundred-percent upside are treated as unreliable; the $32.43 consensus target (+34%) is a better anchor. Solid fundamentals at a full price — a watchlist-eligible mixed profile rather than a high-conviction buy.

Dominant catalyst: today's announced Investor Day (2026-08-25, neutral, unpriced) arriving after the tape demonstrably rewarded the Q2 beat and raised FY2026 outlook (+17.9% pop, holding ~+9% into the window); offset by a Truist price-target trim and post-rally profit-taking. Sentiment delta indeterminate (sparse scored baseline); no severe or moderate red-flag cap fired — a mixed, forming setup.

No run-date source: this input is a partial run (company.cached=true) with no runDate in the envelope. Per the run-date rule the stage fails closed — the inherited currentDate 2026-08-26 comes from the cached upstream stage and is untrusted, so chart windows, event windows, and the staleness lag cannot be computed honestly. The indicator suite was therefore not run; all 18 indicator values are emitted as 0 (unavailable), not as live readings, and the technical score is capped at 2 (degraded read; no tradeable score).